Geode Capital Management’s Valion Bio VBIO Stock Holding History

Geode Capital Management’s Portfolio VBIO Stock Details VBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-775	Closed	-$10.1K	–	4512
2026 Q2	$10.1K	Sell	775 -2,738	-78%	-$59.6K	﹤0.01%	4422
2026 Q1	$77.8K	Buy	+3,513	New	+$89.9K	﹤0.01%	4195
2025 Q1	–	Sell	-86	Closed	-$12.4K	–	4506
2024 Q4	$12.4K	Hold	86	–	–	﹤0.01%	4425
2024 Q3	$9.1K	Sell	86 -1	-1%	-$151	﹤0.01%	4483
2024 Q2	$14.3K	Buy	87 +56	+181%	+$17.6K	﹤0.01%	4509
2024 Q1	$16K	Buy	31 +4	+15%	+$2.31K	﹤0.01%	4508
2023 Q4	$20.6K	Buy	+27	New	+$19.4K	﹤0.01%	4510

Other funds holding VBIO

Murchinson Toronto, Ontario, Canada $908M AUM 36.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return

Geode Capital Management's VBIO Position: Q3 2026 in Review

Geode Capital Management sold out of Valion Bio (VBIO) in Q3 2026, closing a stake of 775 shares — an estimated $10.1K sold.

Geode Capital Management first reported a position in VBIO in Q4 2023 and held it in 7 quarters. The position peaked at $77.8K in Q1 2026. 5 funds tracked by Wall St. Rank hold VBIO as of Q3 2026.

Geode Capital Management reported no remaining Valion Bio position as of Q3 2026 after selling out during the quarter.
Geode Capital Management sold 775 Valion Bio shares in Q3 2026, an estimated $10.1K.
Geode Capital Management first reported a position in Valion Bio in Q4 2023 and held it in 7 quarters.
Geode Capital Management's Valion Bio position peaked at $77.8K in Q1 2026.
5 funds tracked by Wall St. Rank held Valion Bio as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.